CMS recently added two HCPCS codes that organizations can use to bill for PEMGARDA (pemivibart), a monoclonal antibody product for the pre-exposure prophylaxis of COVID-19 in certain adults and adolescents.
Deanne Wilk, MPS, BSN, RN, CCDS, CCDS-O, CDIP, CCS, discusses how her 2024 Revenue Integrity Symposium session will help attendees use technology and collaboration to tackle denials management.
The deadline to apply for the 2024 NAHRI Scholarship has been extended to May 28. The NAHRI Scholarship awards registration to the Revenue Integrity Symposium (RIS) to one recipient.
CMS recently published an FAQ on the Change Healthcare/Optum payment disruption (CHOPD) accelerated and advance payments being issued to Part A providers and Part B suppliers experiencing delays in claims payments due to the recent cyberattack on Change Healthcare.
NAHRI is excited to announce the release of the 2024 Revenue Integrity Symposium (RIS) agenda. RIS, to be held September 12–13 in Oak Brook, Illinois, has expanded to three tracks this year.